A study has found that among patients with prehypertension and coronary artery disease, use of the renin (an enzyme secreted by the kidneys) inhibitor aliskiren, compared with placebo, did not result in improvement or slowing in the progression of coronary atherosclerosis. The study was study published by iJAMA/i. The study is being released early online to coincide with its presentation at the European Society of Cardiology Congress 2013. "Guidelines recommend ...You have just read an article categorized health
titled In Patients With Prehypertension Medication Does Not Slow Progression of Coronary Disease Finds Study.
Written by:
editor - Thursday, September 5, 2013
There are currently no comments for "In Patients With Prehypertension Medication Does Not Slow Progression of Coronary Disease Finds Study"
Post a Comment